185 related articles for article (PubMed ID: 18429725)
1. Tissue plasminogen activator for acute ischaemic stroke.
Fatovich DM
Med J Aust; 2008 Apr; 188(8):489; author reply 490. PubMed ID: 18429725
[No Abstract] [Full Text] [Related]
2. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little.
Hoffman JR
Med J Aust; 2003 Oct; 179(7):333-4. PubMed ID: 14503891
[No Abstract] [Full Text] [Related]
3. rt-PA for ischaemic stroke: what will the next question be?
Leys D; Cordonnier C
Lancet; 2012 Jun; 379(9834):2320-1. PubMed ID: 22632906
[No Abstract] [Full Text] [Related]
4. Thrombolysis for acute ischaemic stroke: revisiting the evidence.
Bailey PM
Med J Aust; 2003 Oct; 179(7):388; author reply 388-9. PubMed ID: 14601632
[No Abstract] [Full Text] [Related]
5. Thrombolysis for acute ischaemic stroke: revisiting the evidence.
Smith BJ
Med J Aust; 2003 Oct; 179(7):386-7; discussion 387. PubMed ID: 14503907
[No Abstract] [Full Text] [Related]
6. Thrombolysis for acute ischaemic stroke: revisiting the evidence.
Johnson KR
Med J Aust; 2003 Oct; 179(7):387-8; author reply 388-9. PubMed ID: 14601631
[No Abstract] [Full Text] [Related]
7. Early phase combined therapeutic management of acute ischaemic stroke.
Bassi P; Lattuada P; Tonietti S
Neurol Sci; 2005 May; 26 Suppl 1():S29-30. PubMed ID: 15883687
[TBL] [Abstract][Full Text] [Related]
8. Breaking up is hard to do: tenecteplase in acute stroke.
Schwamm LH
Lancet Neurol; 2015 Apr; 14(4):343-5. PubMed ID: 25726503
[No Abstract] [Full Text] [Related]
9. Door-to-needle times in acute ischemic stroke: how low can we go?
Smith EE; von Kummer R
Neurology; 2012 Jul; 79(4):296-7. PubMed ID: 22622861
[No Abstract] [Full Text] [Related]
10. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
Schestatsky P; Picon PD
Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
[No Abstract] [Full Text] [Related]
11. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
Liao X; Wang Y; Wang Y
Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
[No Abstract] [Full Text] [Related]
12. Alteplase not yet proven for acute ischaemic stroke.
Bath P
Lancet; 1998 Oct; 352(9136):1238-9. PubMed ID: 9788448
[No Abstract] [Full Text] [Related]
13. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
Chao AC; Po HL; Chan L
Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
[No Abstract] [Full Text] [Related]
14. Should physicians give tPA to patients with acute ischemic stroke? Against: and just what is the emperor of stroke wearing?
Hoffman JR
West J Med; 2000 Sep; 173(3):149-50. PubMed ID: 10986160
[No Abstract] [Full Text] [Related]
15. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
Wardlaw JM; Sandercock PA; Murray V
BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748
[No Abstract] [Full Text] [Related]
16. Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke.
Essig F; Kollikowski AM; Müllges W; Stoll G; Haeusler KG; Schuhmann MK; Pham M
JAMA Neurol; 2021 May; 78(5):615-617. PubMed ID: 33683294
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator for acute ischaemic stroke.
Hurley JC
Med J Aust; 2008 Apr; 188(8):488; author reply 489-90. PubMed ID: 18429722
[No Abstract] [Full Text] [Related]
18. Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.
Fan X; Yu Z; Liu J; Liu N; Hajjar KA; Furie KL; Lo EH; Wang X
Stroke; 2010 Oct; 41(10 Suppl):S54-8. PubMed ID: 20876506
[TBL] [Abstract][Full Text] [Related]
19. [Thrombolytic therapy: formation and current practice of intravenous thrombolysis in acute ischemic stroke].
Iavorskaia VA; Flomin IuV; D'olog NV; Grebeniuk AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():13-27. PubMed ID: 16447549
[TBL] [Abstract][Full Text] [Related]
20. Should physicians give tPA to patients with acute ischemic stroke? For: thrombolytics in stroke: whose risk is it anyway?
Robinson DJ
West J Med; 2000 Sep; 173(3):148-9. PubMed ID: 10986159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
